Brassicaceae-Derived Anticancer Agents: Towards a Green Approach to Beat Cancer

Area of Science:

• Oncology
• Nutritional Science
• Pharmacology

Background:

• Cancer remains a leading global cause of death, with treatments often causing toxic side effects.
• Brassica vegetables, integral to the Mediterranean diet, are recognized for their health benefits, including chronic disease prevention.
• Bioactive compounds from Brassica vegetables show promise as novel anti-cancer therapeutics.

Purpose of the Study:

• To review the anti-tumor effects of Brassica metabolites against various cancer types.
• To examine the influence of processing and biofortification on these compounds' efficacy.
• To consider the role of microbiota in modulating the bioactivity of Brassica compounds.

Main Methods:

• Literature review of studies on Brassica vegetable compounds and their anti-cancer activities.
• Analysis of research on food processing and biofortification techniques affecting Brassica metabolites.
• Inclusion of studies investigating the interaction between gut microbiota and Brassica-derived compounds.

Main Results:

• Identified specific Brassica compounds and their targeted anti-cancer activities across different tumor types.
• Detailed the effects of industrial and domestic processing on the functional properties of these bioactive compounds.
• Highlighted strategies for enhancing health-promoting metabolite content in Brassica plants via biofortification.
• Discussed the significant impact of microbiota on the bioactivity and efficacy of Brassica metabolites.

Conclusions:

• Brassica metabolites offer a promising avenue for developing effective anti-cancer drugs with potentially fewer side effects.
• Understanding processing, biofortification, and microbiota interactions is crucial for maximizing the therapeutic potential of Brassica compounds.
• Further research into these compounds could lead to novel, plant-based cancer treatment strategies.